Daiwa Securities Group Inc. Harmony Biosciences Holdings, Inc. Transaction History
Daiwa Securities Group Inc.
- $21.6 Billion
- Q3 2024
A detailed history of Daiwa Securities Group Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 189 shares of HRMY stock, worth $6,237. This represents 0.0% of its overall portfolio holdings.
Number of Shares
189
Previous 189
-0.0%
Holding current value
$6,237
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding HRMY
# of Institutions
240Shares Held
45.2MCall Options Held
103KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$370 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$193 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$115 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$86 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$63.6 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.95B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...